Literature DB >> 3000003

Studies on gene transfer and reversion to UV resistance in xeroderma pigmentosum cells.

R A Schultz, D P Barbis, E C Friedberg.   

Abstract

We have examined several parameters which address the feasibility of complementing the UV-sensitive phenotype of xeroderma pigmentosum (XP) fibroblasts by gene transfer. We present a comparative study which demonstrates that, relative to immortalized cells, human diploid cells are poor recipients for gene transfer. As measured by both transient and stable expression assays, diploid fibroblasts were completely refractory to DNA transfer by calcium phosphate coprecipitation and exhibited substantially reduced levels of expression following gene transfer by fusion with E. coli protoplasts. We also examined the significance of reversion of the phenotype of UV sensitivity in SV40-immortalized XP-A cell lines. In addition to confirming a previous report of reversion to wild-type levels of UV resistance at a frequency of approximately 10(-7), we have attempted to facilitate the identification of XP-A cells complemented with genomic DNA by employing less stringent selection schemes and cotransfection of a selectable marker. Under these conditions, we observed an increased frequency of reversion and were unable to identify true transfectants.

Entities:  

Mesh:

Year:  1985        PMID: 3000003     DOI: 10.1007/bf01534726

Source DB:  PubMed          Journal:  Somat Cell Mol Genet        ISSN: 0740-7750


  12 in total

1.  Complementation of a DNA repair defect in xeroderma pigmentosum cells by transfer of human chromosome 9.

Authors:  G P Kaur; R S Athwal
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

2.  Partial complementation of the Fanconi anemia defect upon transfection by heterologous DNA. Phenotypic dissociation of chromosomal and cellular hypersensitivity to DNA cross-linking agents.

Authors:  C Diatloff-Zito; F Rosselli; J Heddle; E Moustacchi
Journal:  Hum Genet       Date:  1990-12       Impact factor: 4.132

3.  Molecular cloning of the human DNA excision repair gene ERCC-6.

Authors:  C Troelstra; H Odijk; J de Wit; A Westerveld; L H Thompson; D Bootsma; J H Hoeijmakers
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

4.  Unique DNA repair properties of a xeroderma pigmentosum revertant.

Authors:  J E Cleaver; F Cortés; L H Lutze; W F Morgan; A N Player; D L Mitchell
Journal:  Mol Cell Biol       Date:  1987-09       Impact factor: 4.272

5.  Microcell-mediated transfer of a single human chromosome complements xeroderma pigmentosum group A fibroblasts.

Authors:  R A Schultz; P J Saxon; T W Glover; E C Friedberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

Review 6.  Identification of human genes involved in repair and tolerance of DNA damage.

Authors:  B Kaina; G Fritz; T Coquerelle
Journal:  Radiat Environ Biophys       Date:  1991       Impact factor: 1.925

7.  Repair-deficient xeroderma pigmentosum cells made UV light resistant by fusion with X-ray-inactivated Chinese hamster cells.

Authors:  D Karentz; J E Cleaver
Journal:  Mol Cell Biol       Date:  1986-10       Impact factor: 4.272

8.  Repair of damaged DNA by extracts from a xeroderma pigmentosum complementation group A revertant and expression of a protein absent in its parental cell line.

Authors:  C J Jones; J E Cleaver; R D Wood
Journal:  Nucleic Acids Res       Date:  1992-03-11       Impact factor: 16.971

9.  Efficient cDNA cloning by direct phenotypic correction of a mutant human cell line (HPRT-) using an Epstein-Barr virus-derived cDNA expression vector.

Authors:  P B Belt; W Jongmans; J de Wit; J H Hoeijmakers; P van de Putte; C Backendorf
Journal:  Nucleic Acids Res       Date:  1991-09-25       Impact factor: 16.971

10.  Human chromosome 15 confers partial complementation of phenotypes to xeroderma pigmentosum group F cells.

Authors:  P J Saxon; R A Schultz; E J Stanbridge; E C Friedberg
Journal:  Am J Hum Genet       Date:  1989-04       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.